Clinical Trial

Efficacy of an AFCN Proxy Block in Post-TKA Multimodal Pain Management

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled trial evaluates the additive effect of Supra-Sartorial Subcutaneous Infiltration (SSSI) when performed in combination with intermittent adductor canal block (iACB) and posterior capsule local infiltration analgesia (PC-LIA) for pain management after total knee arthroplasty (TKA). SSSI, an easy-to-perform tentative proxy block to targeted anterior femoral cutaneous nerve (AFCN) block, is tested in 90 adults (45-90 years) randomized into two arms: active SSSI versus sham SSSI. Primary outcome is pain scores at rest and during movement on postoperative day 0; secondary outcomes include daily pain trajectory at rest and during movement, functional recovery scores, rescue analgesic doses over days 0-3, and quality of recovery assessment on day 4.
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-07-02
notable Primary completion pushed: 2027-06 -> 2027-08-01 2026-07-02
minor Completion pushed: 2027-07 -> 2027-09-01 2026-07-02
Trial Details
NCT Number NCT07191964
Lead Sponsor Taipei Medical University WanFang Hospital
Conditions Postoperative Pain Management in Total Knee Arthroplasty
Enrollment 90 participants
Start Date 2026-08-01
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-01